This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Njai, H. F.
Right arrow Articles by Janssens, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Njai, H. F.
Right arrow Articles by Janssens, W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2004, p. 1428-1433, Vol. 42, No. 4
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.4.1428-1433.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Development, Evaluation, and Validation of an Oligonucleotide Probe Hybridization Assay To Subtype Human Immunodeficiency Virus Type 1 Circulating Recombinant Form CRF02_AG

Harr F. Njai,1 Gert Van der Auwera,2 Chiambah A. Ngong,1 Leo Heyndrickx,1 Souleymane Sawadago,3 Hilton Whittle,4 Phillipe Nyambi,5 Robert Colebunders,1 Guido van der Groen,1 and Wouter Janssens1,6*

Department of Microbiology, Institute of Tropical Medicine, Antwerp,1 Department of Plant Systems Biology, University of Ghent, Ghent,2 Flanders Interuniversity Institute for Biotechnology (VIB), Zwijnaarde, Belgium,6 Projet RETRO-CI, Abidjan, Côte d'Ivoire,3 Medical Research Council Laboratories, Fajara, The Gambia,4 Department of Pathology, New York University School of Medicine, New York, New York5

Received 4 June 2003/ Returned for modification 25 September 2003/ Accepted 24 December 2003

We have developed and validated an oligonucleotide probe hybridization assay for human immunodeficiency virus type 1 (HIV-1) circulating recombinant form (CRF) CRF02_AG. In the p17 coding region of the gag gene, a CRF02_AG-specific signature pattern was observed. Five working probes were designed to discriminate CRF02_AG infections from infections by all other documented subtypes and CRFs in an enzyme-linked immunosorbent assay-based oligonucleotide probe hybridization assay. Nucleic acids were extracted from a panel of HIV-1-positive plasma samples from Cameroon, Bénin, Côte d'Ivoire, Kenya, Zambia, and Belgium and from blood spots from The Gambia. CRF02_AG (n = 147) and non-CRF02 (n = 100) samples were analyzed to evaluate and validate the oligonucleotide probe hybridization assay. The CRF02_AG-specific oligonucleotide probe hybridization assay has a high sensitivity and specificity, with good positive and negative predictive values in regions of high and low prevalence. A validation of the assay with West and West Central African samples indicated a sensitivity of 98.4% and a specificity of 96.7%. The oligonucleotide probe hybridization assay as a diagnostic tool will allow for rapid screening for CRF02_AG. This could be used to track the HIV epidemic in terms of documenting the real prevalence of CRF02_AG strains and will complement efforts in vaccine development. Moreover, this technology can easily be applied in laboratories in developing countries.


* Corresponding author. Mailing address: Department of Microbiology, Institute of Tropical Medicine, Nationalestraat 155, B-2000 Antwerp, Belgium. Phone: 32 3 247 63 28. Fax: 32 3 247 63 33. E-mail: wjanssens{at}itg.be.


Journal of Clinical Microbiology, April 2004, p. 1428-1433, Vol. 42, No. 4
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.4.1428-1433.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Vega, Y., Perez-Alvarez, L., Delgado, E., Munoz, M., Casado, G., Carmona, R., Sierra, M., Vazquez de Parga, E., Pinilla, M., Garcia, V., Medrano, L., Contreras, G., Thomson, M., Najera, R. (2005). Oligonucleotide Ligation Assay for Detection of Mutations Associated with Reverse Transcriptase and Protease Inhibitor Resistance in Non-B Subtypes and Recombinant Forms of Human Immunodeficiency Virus Type 1. J. Clin. Microbiol. 43: 5301-5304 [Abstract] [Full Text]